<DOC>
	<DOCNO>NCT02756728</DOCNO>
	<brief_summary>The purpose study investigate safety efficacy administer BI-505 conjunction high dose melphalan stem cell transplantation multiple myeloma patient .</brief_summary>
	<brief_title>A Phase I/II Study BI-505 Conjunction With Autologous Stem Cell Transplant Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<criteria>A diagnosis multiple myeloma 2014 IMWG criterion recommend undergo HDM + ASCT standardofcare therapy multiple myeloma . Subjects must adequate vital organ function functional status HDM + ASCT Subjects must collect cryopreserved ≥4x106 hematopoietic stem cell per kg actual body weight suitable use autologous stem cell transplantation judgment investigator . At time enrollment , subject must least partial response , define IMWG criterion comparison baseline/pretreatment parameter , induction regimen contain lenalidomide and/or bortezomib . Subjects must measurable disease accord one follow criterion : 1 . Serum Mspike ≥0.1 g/dl 2 . Urine Mspike &gt; 200 mg 24hour urine collection 3 . Involved serum free light chain upper limit normal serum free light chain ratio outside normal range . At time enrollment , subject must within 12 month first dose initial/induction therapy , anticipate day ASCT must within 12 month first dose initial/induction therapy Prior allogeneic autologous hematopoietic stem cell transplant Current active infection , include HIV hepatitis C B Autoimmune disease require ongoing immunosuppressive therapy . History atrial fibrillation flutter , include paroxysmal atrial fibrillation flutter . History transient ischemic attack stroke . At time enrollment , subject must require multiagent continuousinfusion cytotoxic chemotherapy ( e.g. , regimens DPACE ) part initial/induction therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>